BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18847048)

  • 1. [Biosynthesis, storage and release of dopamine at the level of the dopaminergic nigro-neostriatal system].
    Glowinski J
    Arch Ital Biol; 1973 Dec; 111(3-4):504-15. PubMed ID: 18847048
    [No Abstract]   [Full Text] [Related]  

  • 2. Nigro-neostriatal dopaminergic activity and axonal protein transport during morphinization and withdrawal in rats.
    Iwamoto ET; Craves RB; Loh HH; Meyerhof J; Way EL
    Proc West Pharmacol Soc; 1975; 18():288-93. PubMed ID: 1237141
    [No Abstract]   [Full Text] [Related]  

  • 3. Nigrostriatal dopamine neurons, D1 transmission in basal and ischemic states and protective effects of gangliosides.
    Agnati LF; Fuxe K
    Lab Invest; 1990 Sep; 63(3):283-97. PubMed ID: 1975632
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):101-5. PubMed ID: 4267960
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop.
    Pierce RC; Clemens AJ; Grabner CP; Rebec GV
    J Neurochem; 1994 Oct; 63(4):1499-507. PubMed ID: 7931303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain monoamines. Biosynthesis and fate.
    Axelrod J
    Neurosci Res Program Bull; 1971 Mar; 9(2):188-96. PubMed ID: 4152628
    [No Abstract]   [Full Text] [Related]  

  • 7. Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding.
    Sotak BN; Hnasko TS; Robinson S; Kremer EJ; Palmiter RD
    Brain Res; 2005 Nov; 1061(2):88-96. PubMed ID: 16226228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-propanoylmannosamine interferes with O-GlcNAc modification of the tyrosine 3-monooxygenase and stimulates dopamine secretion.
    Bork K; Kannicht C; Nöhring S; Reutter W; Weidemann W; Hart GW; Horstkorte R
    J Neurosci Res; 2008 Feb; 86(3):647-52. PubMed ID: 17896794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.
    Walters JR; Roth RH
    J Pharmacol Exp Ther; 1974 Oct; 191(1):82-91. PubMed ID: 4153880
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic neurons--alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow.
    Morgenroth VH; Walters JR; Roth RH
    Biochem Pharmacol; 1976 Mar; 25(6):655-61. PubMed ID: 6035
    [No Abstract]   [Full Text] [Related]  

  • 12. The Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo.
    Cheng HC; Burke RE
    J Neurochem; 2010 May; 113(3):683-91. PubMed ID: 20132467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the adrenergic innervation of cerebral arteries after exposure of the rat rostral neostriatal dopaminergic system].
    Pugovkin AP; Iakimovskiĭ AF
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(1-2):143-5. PubMed ID: 13677000
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of nigrostriatal and tuberoinfundibular-hypophyseal dopaminergic neurons.
    Moore KE; Wuerthele SM
    Prog Neurobiol; 1979; 13(3):325-59. PubMed ID: 42118
    [No Abstract]   [Full Text] [Related]  

  • 15. gamma-Hydroxybutyrate: effects on nonstriatal dopaminergic neurons.
    Roth RH; Nowycky MC; Walters JR; Morgenroth VH
    Adv Biochem Psychopharmacol; 1977; 16():483-8. PubMed ID: 18897
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosynthesis of heart catecholamines.
    Masuoka DT; Alcaraz AF
    Arch Int Pharmacodyn Ther; 1966 Jan; 159(1):144-53. PubMed ID: 5918754
    [No Abstract]   [Full Text] [Related]  

  • 17. A mouse juvenile or adult slice with preserved functional nigro-striatal dopaminergic neurons.
    Ammari R; Lopez C; Fiorentino H; Gonon F; Hammond C
    Neuroscience; 2009 Mar; 159(1):3-6. PubMed ID: 19032976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats.
    Mizoguchi K; Shoji H; Tanaka Y; Maruyama W; Tabira T
    Neuroscience; 2009 Sep; 162(4):1192-201. PubMed ID: 19463906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of scoparone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.
    Yang YJ; Lee HJ; Huang HS; Lee BK; Choi HS; Lim SC; Lee CK; Lee MK
    J Neurosci Res; 2009 Jun; 87(8):1929-37. PubMed ID: 19185027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroanatomical characterization of a new mutant rat with dopamine depletion in the substantia nigra.
    Clarke DJ; Payne AP
    Eur J Neurosci; 1994 May; 6(5):885-8. PubMed ID: 7915606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.